19.50
+0.62(+3.28%)
Currency In USD
| Previous Close | 18.88 |
| Open | 18.85 |
| Day High | 19.65 |
| Day Low | 18.5 |
| 52-Week High | 22.55 |
| 52-Week Low | 9.12 |
| Volume | 424,158 |
| Average Volume | 1.04M |
| Market Cap | 790.5M |
| PE | 12.5 |
| EPS | 1.56 |
| Moving Average 50 Days | 18.64 |
| Moving Average 200 Days | 15.33 |
| Change | 0.62 |
If you invested $1000 in Keros Therapeutics, Inc. (KROS) since IPO date, it would be worth $971.12 as of January 14, 2026 at a share price of $19.5. Whereas If you bought $1000 worth of Keros Therapeutics, Inc. (KROS) shares 5 years ago, it would be worth $259.03 as of January 14, 2026 at a share price of $19.5.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Keros Therapeutics Announces Final Results of Tender Offer
GlobeNewswire Inc.
Nov 20, 2025 9:01 PM GMT
LEXINGTON, Mass., Nov. 20, 2025 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (“Keros” or the “Company”) (Nasdaq: KROS), today announced the final results of its cash tender offer (the “Tender Offer”) to repurchase up to 10,950,165 shares of its com
Keros Therapeutics Announces Preliminary Results of Tender Offer
GlobeNewswire Inc.
Nov 19, 2025 11:00 AM GMT
LEXINGTON, Mass., Nov. 19, 2025 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (“Keros” or the “Company”) (Nasdaq: KROS), today announced the preliminary results of its cash tender offer (the “Tender Offer”) to repurchase up to 10,950,165 shares of i
Keros Therapeutics Commences Issuer Tender Offer to Repurchase up to $194.4 Million Shares
GlobeNewswire Inc.
Oct 20, 2025 10:00 AM GMT
LEXINGTON, Mass., Oct. 20, 2025 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (“Keros” or the “Company”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapeutics to treat a wide range of